Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 61,419 $ 62,632
Equity method investments 3,263,391 2,966,305
Receivables 3,112,810 3,073,855
Receivables held-for-sale 5,422 35,299
Real estate 2,992 111,036
Investments 7,223 7,165
Securitization assets, net of allowance of $3 million and $3 million, respectively 220,003 218,946
Other assets 54,690 77,112
Total Assets 6,727,950 6,552,350
Liabilities:    
Accounts payable, accrued expenses and other 203,753 163,305
Credit facilities 201,270 400,861
Commercial paper notes 65,278 30,196
Term loans payable 692,777 727,458
Senior unsecured notes 2,550,058 2,318,841
Convertible notes 608,102 609,608
Total Liabilities 4,454,535 4,410,725
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 113,475,576 and 112,174,279 shares issued and outstanding, respectively 1,135 1,122
Additional Paid in Capital, Common Stock 2,415,118 2,381,510
Accumulated deficit (227,820) (303,536)
Accumulated other comprehensive income (loss) 29,111 13,165
Non-controlling interest 55,871 49,364
Total Stockholders’ Equity 2,273,415 2,141,625
Total Liabilities and Stockholders’ Equity 6,727,950 6,552,350
Non-recourse debt    
Liabilities:    
Non-recourse debt (secured by assets of $304 million and $239 million, respectively) $ 133,297 $ 160,456